TABLE 1

Registration status of bedaquiline and delamanid globally^#^,^¶

	Countries in which the medicines have been registered⁺	Countries in which regulatory dossiers have been filed
Bedaquiline	Armenia, China, EU,^§ Hong Kong, India, Moldova, New Zealand, Peru, Philippines, Russia, South Africa, South Korea, Taiwan, Thailand, Turkey, Turkmenistan, USA, Uzbekistan	Bangladesh, Brazil, Burundi,^ƒ Cameroon,^ƒ Ethiopia,^ƒ Ghana,^ƒ Indonesia, Japan, Kenya,^ƒ Mexico, Nigeria,^ƒ Rwanda,^ƒ Tanzania,^ƒ Uganda,^ƒ Vietnam
Delamanid	EU,^§ Hong Kong, India, Japan, Philippines, South Korea, Turkey	China, Indonesia, Peru, South Africa

^#: data are up to date as of October 2017. ^¶: the countries in italics are multidrug-resistant tuberculosis high burden countries. ⁺: in Colombia, bedaquiline is in the country's list of “Medicamentos Vitales No Disponibles”, as an interim alternative for local registration; and in Macau, bedaquiline is considered to be registered in the country, via import licensing, although no formal regulatory approval was pursued by Jannsen. ^§: number of countries included in European Medicines Agency approval is 31. ^ƒ: countries are part of the World Health Organization collaborative registration procedure for stringent regulatory authority-approved products.